REGINA – Patients in Saskatchewan with a rare form of cystic fibrosis will soon have access to a new oral medication.
The province announced Thursday it will provide coverage of Kalydeco starting Sept. 1.
Health Minister John Duncan said the “drug can help improve the quality of life and lung function for cystic fibrosis patients.”
The move is being applauded by Cystic Fibrosis Canada, who said it is compassionate action that will benefit the health and well-being of patients.
Alberta and Ontario are the only other provinces providing coverage.
Last year, around 130 patients in Saskatchewan were covered for approved cystic fibrosis medication listed by the Saskatchewan drug plan at a cost of roughly $1.75 million.